$5.36
-0.015-0.28%
Last update: Nov 11, 12:36 PM
Cormedix Inc
CRMDNASDAQ
Cormedix fell 52.0% from $11.19 to $5.37, behind the S&P 500's +9.8%. Its worst day was Jan 8 (−32.8%), and its low came Nov 5 at $5.23.
Nov 11, 2025 – Nov 10, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $0.57 beat the $0.57 estimate on $104.3M revenue (est. $86.0M); Q4 revenue guidance of $115.0M–$135.0M against the $127.2M consensus.
+2.1% · S&P 500 +0.1%
Story events cover the past 12 months · Times ET
Cormedix closed at its highest level of the year, 13.8% above where the year started.
+1.6% · S&P 500 −0.4%
Cormedix shares fell 32.8%, while the S&P 500 fell 0.0%.
−32.8%, the year's worst day, on 24M shares, the year's heaviest volume · S&P 500 0.0%
EPS of $0.61 missed the $0.83 estimate on $128.6M revenue (est. $127.1M); FY revenue guidance of $300.0M–$320.0M against the $309.5M consensus.
−11.5% · S&P 500 −0.6%
EPS of $0.43 beat the $0.33 estimate on $127.4M revenue (est. $105.9M); FY revenue guidance of $325.0M–$345.0M against the $306.6M consensus.
+5.7% · S&P 500 +0.8%
EPS of $0.29 beat the $0.24 estimate on $101.9M revenue (est. $95.8M); FY revenue guidance of $325.0M–$345.0M against the $334.7M consensus.
+14.6%, the year's best day · S&P 500 +0.7%
Cormedix closed at its lowest level of the year, 53.3% below where the year started.
−7.6% · S&P 500 −4.4%
Where it ended: a close of $5.37 on Nov 10, 2026. Up next: Q3 2026 earnings on Nov 12, 2026 (EPS est. $-0.11, revenue est. $52.7M).
Nothing in the past 12 months.
All CRMD dividend historyReplay the year: the line draws itself and stops at each of the 7 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for CRMD and SPY from Benzinga historical bars. Not investment advice.
